• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HIN
Click for more information
0.00% $2.37

HEARTWARE INTERNATIONAL, INC - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
HINHeartWare to Present at Lazard Capital Circulatory Assist Co20/09/11
HINHeartWare to Present at UBS Global Life Sciences Conference15/09/11
HINChange of Director's Interest Notice14/09/11
HINChange of Director's Interest Notice12/09/11
HINSlide Presentation of MVAD Preclinical Data at ISRBP12/09/11
HINPreclinical Data for Next Generation MVAD Pump PresentedPRICE SENSITIVE12/09/11
HINChange of Director's Interest Notice08/09/11
HINChange of Director's Interest Notice26/08/11
HINOptions Grant - ASX Appendix 3B24/08/11
HINASX Appendix 3B - Options Exercise24/08/11
HINHeartWare to Present at Wedbush Securities 2011 Health Care15/08/11
HINHeartWare to Present at Canaccord Genuity 31st Annual Growth09/08/11
HINASX Appendix 3B - Option Exercise and Vesting08/08/11
HINAppendix 4D and Half Year Financial StatementPRICE SENSITIVE08/08/11
HINReports Second Quarter 2011 Revenues of US$20.4 MillionPRICE SENSITIVE05/08/11
HINChange of Director's Interest Notice03/08/11
HINSecond Quarter Financial Results Call28/07/11
HINReimbursement Approval in FrancePRICE SENSITIVE28/06/11
HINInitiation of pre-arranged trading plan28/06/11
HINASX Appendix 3B - Option Grant28/06/11
HINChange of Director's Interest Notice28/06/11
HINOptions Exercise - ASX Appendix 3B28/06/11
HINWebcast slides (with clinical update) from Wells Fargo 2011PRICE SENSITIVE23/06/11
HINHeartWare to present at Wells Fargo 2011 Healthcare Conferen17/06/11
HINASX Appendix 3B - Option Exercise27/05/11
HINChange of Director's Interest Notice23/05/11
HINChange of Director's Interest Notice20/05/11
HINChange of Director's Interest Notice20/05/11
HINChange of Director's Interest Notice17/05/11
HINGrant of Incentive Equity - Appendix 3B17/05/11
HINAnnual General Meeting Results13/05/11
HINAnnual General Meeting Materials12/05/11
HINFirst Quarter 2011 Financial Results09/05/11
HINChange of Director's Interest09/05/11
HINHeartWare to Present at Bank of America Merrill Lynch Health09/05/11
HINASX Appendix 3B - Option Exercise and Vesting09/05/11
HINReports First Quarter 2011 Revenues of US$18 MillionPRICE SENSITIVE06/05/11
HINFirst Quarter Financial Results Call27/04/11
HINHeartWare Supplemental Addendum to CE Mark Accepted by BSIPRICE SENSITIVE27/04/11
HINPresentation of BTT and CAP data at ISHLT 201118/04/11
HINHeartWare BTT and CAP data presented at ISHLT 2011PRICE SENSITIVE18/04/11
HINAnnounces ISHLT presentations, 1,000 global implants13/04/11
HINNotice of Annual General Meeting11/04/11
HINHeartWare receives approval from TGA in AustraliaPRICE SENSITIVE25/03/11
HINU.S. FDA accepts HeartWare PMA filing for reviewPRICE SENSITIVE18/03/11
HINOption Exercise - ASX Appendix 3B17/03/11
HINExercise of Stock Options - ASX Appendix 3B09/03/11
HINHeartWare to present at Barclays Capital Global Healthcare C08/03/11
ACL +SandP Announces March SP/ASX Rebalance04/03/11
HINOption Grant - ASX Appendix 3B03/03/11
HINASX Appendix 3B - Option Exercise and Vesting of RSUs01/03/11
HINChange of Director's Interest Notice01/03/11
HINAnnual Report for 2010 and ASX Appendix 4EPRICE SENSITIVE28/02/11
HINReports Q4 rev. of US$20.9M and annual rev. of US$55MPRICE SENSITIVE25/02/11
HINFourth Quarter Earnings Release Call16/02/11
HINAmended Change of Director's Interest Notice28/01/11
HINOption Exercise - ASX Appendix 3B27/01/11
HINChange of Director's Interest Notice27/01/11
HINFDA Grants HeartWare 94-Patient Allotment for BTT CAPPRICE SENSITIVE25/01/11
HINHeartWare Named to REVIVE IT Heart Failure Study25/01/11
HINOption Exercise - ASX Appendix 3B18/01/11
HINQ4 2010 Preliminary Revenue and JPM ConferencePRICE SENSITIVE11/01/11
HINOption Exercise - ASX Appendix 3B06/01/11
HINHeartWare to present at JP Morgan Healthcare Conference05/01/11
HINHeartWare Submits PMA to FDA for Bridge-to-TransplantPRICE SENSITIVE29/12/10
HINChange of Director's Notice23/12/10
HINAnnual Employee Equity Allocation / Appendix 3B23/12/10
HINHeartWare Insider Trading Policy21/12/10
HINASX Appendix 3B - HeartWare Converible Notes16/12/10
HINChange in Director's Interest Notice16/12/10
HINProspectus Public Offering of Common Stock and Convertible N16/12/10
HINCompletion of Concurrent Public OfferingsPRICE SENSITIVE16/12/10
HINHeartWare Announces Pricing of Concurrent Public OfferingsPRICE SENSITIVE14/12/10
HINHeartWare Announces Concurrent Public OfferingsPRICE SENSITIVE10/12/10
HINHeartWare to present at Canaccord Genuity conference03/12/10
HINCorrected ASX Appendix 3B01/12/10
HINOption Exercise - ASX Appendix 3B01/12/10
HINOption Exercise - Appendix 3B24/11/10
HINHeartWare to present at annual Piper Jaffray Health Conferen19/11/10
HINADVANCE trial data presentation at AHA 201015/11/10
HINHeartWare Bridge-to-Transplant Data AnnouncementPRICE SENSITIVE15/11/10
HINHeartWare to present at Lazard Annual Healthcare Conference12/11/10
HINClinical Trial Data at AHA, Investor meeting webcast10/11/10
HINThird Quarter 2010 Financial Statements05/11/10
HINThird Quarter ResultsPRICE SENSITIVE04/11/10
HINThird Quarter Earnings Release Call21/10/10
HINOptions Exercise - ASX Appendix 3B06/10/10
HINOption Exercise - ASX Appendix 3B28/09/10
HINHeartWare to Present at Lazard Circulatory Assist Device Day24/09/10
HINOption Exercise - ASX Appendix 3B23/09/10
HINChange of Director's Interest Notice23/09/10
HINHeartWare to Present at UBS Global Life Sciences Conference16/09/10
HINOption Exercise - ASX Appendix 3B06/09/10
HINFDA Grants HeartWare Second Patient Allotment Under CAPPRICE SENSITIVE06/09/10
HINOption Exercise - ASX Appendix 3B19/08/10
HINOption Grant - ASX Appendix 3B19/08/10
HINHeartWare Study to be Late-Breaker at American Heart Assn.12/08/10
HINAppendix 4D and Half Year Financial Statements (US GAAP)PRICE SENSITIVE09/08/10
HINHeartWare Announces Second Quarter ResultsPRICE SENSITIVE06/08/10
HINHeartWare to Present at Canaccord Growth Conference05/08/10
HINHeartWare to Present at Lazard Capital Circulatory Assist Co
20/09/11
HINHeartWare to Present at UBS Global Life Sciences Conference
15/09/11
HINChange of Director's Interest Notice
14/09/11
HINChange of Director's Interest Notice
12/09/11
HINSlide Presentation of MVAD Preclinical Data at ISRBP
12/09/11
HINPreclinical Data for Next Generation MVAD Pump Presented
12/09/11PRICE SENSITIVE
HINChange of Director's Interest Notice
08/09/11
HINChange of Director's Interest Notice
26/08/11
HINOptions Grant - ASX Appendix 3B
24/08/11
HINASX Appendix 3B - Options Exercise
24/08/11
HINHeartWare to Present at Wedbush Securities 2011 Health Care
15/08/11
HINHeartWare to Present at Canaccord Genuity 31st Annual Growth
09/08/11
HINASX Appendix 3B - Option Exercise and Vesting
08/08/11
HINAppendix 4D and Half Year Financial Statement
08/08/11PRICE SENSITIVE
HINReports Second Quarter 2011 Revenues of US$20.4 Million
05/08/11PRICE SENSITIVE
HINChange of Director's Interest Notice
03/08/11
HINSecond Quarter Financial Results Call
28/07/11
HINReimbursement Approval in France
28/06/11PRICE SENSITIVE
HINInitiation of pre-arranged trading plan
28/06/11
HINASX Appendix 3B - Option Grant
28/06/11
HINChange of Director's Interest Notice
28/06/11
HINOptions Exercise - ASX Appendix 3B
28/06/11
HINWebcast slides (with clinical update) from Wells Fargo 2011
23/06/11PRICE SENSITIVE
HINHeartWare to present at Wells Fargo 2011 Healthcare Conferen
17/06/11
HINASX Appendix 3B - Option Exercise
27/05/11
HINChange of Director's Interest Notice
23/05/11
HINChange of Director's Interest Notice
20/05/11
HINChange of Director's Interest Notice
20/05/11
HINChange of Director's Interest Notice
17/05/11
HINGrant of Incentive Equity - Appendix 3B
17/05/11
HINAnnual General Meeting Results
13/05/11
HINAnnual General Meeting Materials
12/05/11
HINFirst Quarter 2011 Financial Results
09/05/11
HINChange of Director's Interest
09/05/11
HINHeartWare to Present at Bank of America Merrill Lynch Health
09/05/11
HINASX Appendix 3B - Option Exercise and Vesting
09/05/11
HINReports First Quarter 2011 Revenues of US$18 Million
06/05/11PRICE SENSITIVE
HINFirst Quarter Financial Results Call
27/04/11
HINHeartWare Supplemental Addendum to CE Mark Accepted by BSI
27/04/11PRICE SENSITIVE
HINPresentation of BTT and CAP data at ISHLT 2011
18/04/11
HINHeartWare BTT and CAP data presented at ISHLT 2011
18/04/11PRICE SENSITIVE
HINAnnounces ISHLT presentations, 1,000 global implants
13/04/11
HINNotice of Annual General Meeting
11/04/11
HINHeartWare receives approval from TGA in Australia
25/03/11PRICE SENSITIVE
HINU.S. FDA accepts HeartWare PMA filing for review
18/03/11PRICE SENSITIVE
HINOption Exercise - ASX Appendix 3B
17/03/11
HINExercise of Stock Options - ASX Appendix 3B
09/03/11
HINHeartWare to present at Barclays Capital Global Healthcare C
08/03/11
ACL +SandP Announces March SP/ASX Rebalance
04/03/11
HINOption Grant - ASX Appendix 3B
03/03/11
HINASX Appendix 3B - Option Exercise and Vesting of RSUs
01/03/11
HINChange of Director's Interest Notice
01/03/11
HINAnnual Report for 2010 and ASX Appendix 4E
28/02/11PRICE SENSITIVE
HINReports Q4 rev. of US$20.9M and annual rev. of US$55M
25/02/11PRICE SENSITIVE
HINFourth Quarter Earnings Release Call
16/02/11
HINAmended Change of Director's Interest Notice
28/01/11
HINOption Exercise - ASX Appendix 3B
27/01/11
HINChange of Director's Interest Notice
27/01/11
HINFDA Grants HeartWare 94-Patient Allotment for BTT CAP
25/01/11PRICE SENSITIVE
HINHeartWare Named to REVIVE IT Heart Failure Study
25/01/11
HINOption Exercise - ASX Appendix 3B
18/01/11
HINQ4 2010 Preliminary Revenue and JPM Conference
11/01/11PRICE SENSITIVE
HINOption Exercise - ASX Appendix 3B
06/01/11
HINHeartWare to present at JP Morgan Healthcare Conference
05/01/11
HINHeartWare Submits PMA to FDA for Bridge-to-Transplant
29/12/10PRICE SENSITIVE
HINChange of Director's Notice
23/12/10
HINAnnual Employee Equity Allocation / Appendix 3B
23/12/10
HINHeartWare Insider Trading Policy
21/12/10
HINASX Appendix 3B - HeartWare Converible Notes
16/12/10
HINChange in Director's Interest Notice
16/12/10
HINProspectus Public Offering of Common Stock and Convertible N
16/12/10
HINCompletion of Concurrent Public Offerings
16/12/10PRICE SENSITIVE
HINHeartWare Announces Pricing of Concurrent Public Offerings
14/12/10PRICE SENSITIVE
HINHeartWare Announces Concurrent Public Offerings
10/12/10PRICE SENSITIVE
HINHeartWare to present at Canaccord Genuity conference
03/12/10
HINCorrected ASX Appendix 3B
01/12/10
HINOption Exercise - ASX Appendix 3B
01/12/10
HINOption Exercise - Appendix 3B
24/11/10
HINHeartWare to present at annual Piper Jaffray Health Conferen
19/11/10
HINADVANCE trial data presentation at AHA 2010
15/11/10
HINHeartWare Bridge-to-Transplant Data Announcement
15/11/10PRICE SENSITIVE
HINHeartWare to present at Lazard Annual Healthcare Conference
12/11/10
HINClinical Trial Data at AHA, Investor meeting webcast
10/11/10
HINThird Quarter 2010 Financial Statements
05/11/10
HINThird Quarter Results
04/11/10PRICE SENSITIVE
HINThird Quarter Earnings Release Call
21/10/10
HINOptions Exercise - ASX Appendix 3B
06/10/10
HINOption Exercise - ASX Appendix 3B
28/09/10
HINHeartWare to Present at Lazard Circulatory Assist Device Day
24/09/10
HINOption Exercise - ASX Appendix 3B
23/09/10
HINChange of Director's Interest Notice
23/09/10
HINHeartWare to Present at UBS Global Life Sciences Conference
16/09/10
HINOption Exercise - ASX Appendix 3B
06/09/10
HINFDA Grants HeartWare Second Patient Allotment Under CAP
06/09/10PRICE SENSITIVE
HINOption Exercise - ASX Appendix 3B
19/08/10
HINOption Grant - ASX Appendix 3B
19/08/10
HINHeartWare Study to be Late-Breaker at American Heart Assn.
12/08/10
HINAppendix 4D and Half Year Financial Statements (US GAAP)
09/08/10PRICE SENSITIVE
HINHeartWare Announces Second Quarter Results
06/08/10PRICE SENSITIVE
HINHeartWare to Present at Canaccord Growth Conference
05/08/10
refresh Created with Sketch. REFRESH
 

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.